Top

Published in:

01-01-2014 | Research Article

CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line

Authors: Xingjun Feng, Guozhuan Miao, Yipeng Han, Yi Xu

Published in: Tumor Biology | Issue 1/2014

Abstract

Caspase recruitment domain-containing membrane-associated guanylate kinase protein 10 or CARMA3 (CARD10) is a recently characterized oncoprotein involved in the progression of several human malignancies. The present study aims to investigate the expression pattern and biological roles of CARMA3 protein in human glioma. CARMA3 expression was analyzed in 97 glioma specimens using immunohistochemistry. We observed negative staining in normal astrocytes and positive staining of CARMA3 in 25 out of 97 (25.8 %) glioma samples. Overexpression of CARMA3 correlated with tumor grade (p < 0.001). Small interfering RNA knockdown was performed in A172 cell line with relatively high CARMA3 expression. Using colony formation assay and Matrigel invasion assay, we showed that CARMA3 depletion in A172 cell line inhibited cell proliferation and cell invasion. In addition, mRNA and protein levels of matrix metallopeptidase 9 (MMP9) were downregulated, indicating CARMA3 might regulate invasion through MMP9. In conclusion, CARMA3 serves as an oncoprotein in human glioma by regulating cell invasion, possibly through MMP9 regulation.

Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10–29.PubMedCrossRef

Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007;17:304–7.PubMedCrossRef

Stupp R, Mason WP, van den Bent MJ, Weller M, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.PubMedCrossRef

Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061–8.

Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol. 2012;138:1971–81.PubMedCrossRef

Shahi MH, Schiapparelli P, Afzal M, Sinha S, et al. Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors. Tumour Biol. 2011;32:113–27.PubMedCrossRef

Yang L, Liu M, Gu Z, Chen J, et al. Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells. Tumour Biol. 2012;33:2255–63.PubMedCrossRef

Zhao T, Miao Z, Wang Z, Xu Y, et al., CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells. Tumour Biol., 2013. doi:10.1007/s13277-013-0869-x

Miao Z, Zhao T, Wang Z, Xu Y, et al. CARMA3 is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression. Biochem Biophys Res Commun. 2012;425:781–7.PubMedCrossRef

10.

Li Z, Qu L, Dong Q, Huang B, et al. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One. 2012;7:e36903.PubMedCentralPubMedCrossRef

11.

Mahanivong C, Chen HM, Yee SW, Pan ZK, et al. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene. 2008;27:1273–80.PubMedCrossRef

12.

Wang L, Guo Y, Huang WJ, Ke X, et al. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem. 2001;276:21405–9.PubMedCrossRef

13.

McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem. 2001;276:30589–97.PubMedCrossRef

14.

Grabiner BC, Blonska M, Lin PC, You Y, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 2007;21:984–96.PubMedCrossRef

15.

McAllister-Lucas LM, Ruland J, Siu K, Jin X, et al. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA. 2007;104:139–44.PubMedCrossRef

16.

Kim MS, Park MJ, Kim SJ, Lee CH, et al. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int J Oncol. 2005;27:839–46.PubMed

17.

Dong QZ, Wang Y, Tang ZP, Fu L, et al. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol. 2013;182:954–64.PubMedCrossRef

18.

Jiang L, Wu J, Yang Y, Liu L, et al. Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer. 2012;12:406.PubMedCentralPubMedCrossRef

19.

Sun J. CARMA3: a novel scaffold protein in regulation of NF-kappaB activation and diseases. World J Biol Chem. 2010;1:353–61.PubMedCentralPubMedCrossRef

20.

McAllister-Lucas LM, Jin X, Gu S, Siu K, et al. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis. J Biol Chem. 2010;285:25880–4.PubMedCrossRef

21.

Maity G, Choudhury PR, Sen T, Ganguly KK, et al. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2010;32:129–38.PubMedCrossRef

22.

Guo D, Zhou H, Wu Y, Zhou F, et al. Involvement of ERK1/2/NF-kappaB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumour Biol. 2011;32:921–30.PubMedCrossRef

23.

Li H, Mittal A, Paul PK, Kumar M, et al. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem. 2009;284:4439–50.PubMedCrossRef

24.

Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, et al. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cell Signal. 2009;21:1109–22.PubMedCrossRef

Title: CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line
Authors: Xingjun Feng
Guozhuan Miao
Yipeng Han
Yi Xu
Publication date: 01-01-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 1/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1018-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma

Tehranolide inhibits cell proliferation via calmodulin inhibition, PDE, and PKA activation

Quantitative assessment of the influence of glutathione S-transferase T1 null variant on gastric cancer risk

Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells

Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation

TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer